Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIntron in HBeAg Positive Chronic Hepatitis B
NCT00536263Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2007
- Primary completion
- Nov 2009
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
01
Overview
A Phase 3 trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Merck & Co.. Started Sep 2007; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00536263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536263.